Destiny Pharma

Developer of drugs for the treatment of infectious diseases

placeBrighton, England, United Kingdom calendar_todayFounded 1997 groups23 employees language destinypharma.com

Registered entities

Investor mix

15 investors on record; lead investors include ACF Investors, Longbow Capital; 1 has since exited.

Investor typeCountShare
Venture capital747%
Private equity213%
Bank & private debt213%
Other / undisclosed427%
Coming soon